Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
S-Adenosyl-L-Homocysteine Hydrolase as Target Enzyme for Antiviral Agents: Studies with Adenosine Kinase-Deficient Rat Cells — Marina Cools (1987) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
S-Adenosyl-L-Homocysteine Hydrolase as Target Enzyme for Antiviral Agents: Studies with Adenosine Kinase-Deficient Rat Cells
Shared by
De Clercq Erik
KU Leuven
S-Adenosyl-L-Homocysteine Hydrolase as Target Enzyme for Antiviral Agents: Studies with Adenosine Kinase-Deficient Rat Cells
Chapter In A Book
1987
en
Authors
MC
Marina Cools
JD
John C. Drach
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1993
S-Adenosyl-L-homocysteine Hydrolase Inhibitors as Anti-Viral Agents: 5′-Deoxyaristeromycin
Suhaib M. Siddiqi
,
Stewart W. Schneller
,
Satoru Ikeda
,
Robert Snoeck
,
Graciela Andreï
,
Jan Balzarini
,
De Clercq Erik
Article
2003
Inactivation of S-Adenosyl-l-Homocysteine hydrolase with novel 5′-thioadenosine derivatives. Antiviral effects
Georges Guillerm
,
D. Guillerm
,
Corinne Vandenplas‐Vitkowski
,
Cédric Glapski
,
De Clercq Erik
Article
2003
Inactivation of S‐Adenosyl‐L‐homocysteine Hydrolase with Novel 5′‐Thioadenosine Derivatives. Antiviral Effects.
Georges Guillerm
,
D. Guillerm
,
Corinne Vandenplas‐Vitkowski
,
Cederic Glapski
,
De Clercq Erik
Article
1982
ChemInform Abstract: STUDIES ON S‐ADENOSYL‐L‐HOMOCYSTEINE HYDROLASE. PART V. SYNTHESIS AND ANTIVIRAL ACTIVITY OF STEREOISOMERIC ERITADENINES
A. HOLY
,
Ivan Votruba
,
De Clercq Erik
Article
2002
Sugar‐Modified Conjugated Diene Analogues of Adenosine and Uridine: Synthesis, Interaction with S‐Adenosyl‐L‐homocysteine Hydrolase, and Antiviral and Cytostatic Effects.
Stanislaw F. Wnuk
,
Bong‐Oh Ro
,
Carlos A. Valdez
,
Elżbieta Lewandowska
,
Neida X. Valdez
,
Pablo R. Sacasa
,
Dan Yin
,
Jinsong Zhang
,
Ronald T. Borchardt
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.